Advance NanoTek (ASX:ANO) - Managing Director, Geoff Acton
Managing Director, Geoff Acton
Sourced: Advance NanoTek
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Advance Nanotek (ANO) has teamed up with Astivita (AIR) to create an antimicrobial hand, face and body moisturiser
  • The moisturiser will include SPF15, with a percentage of zinc and hinokitiol
  • The companies have filed for a joint patent application
  • There is no claims this product with cure or stop contracting COVID-19
  • However, the product has been sent to MSL Solution to test its effectiveness against the virus
  • On market close, Advance Nanotek is up 1.18 per cent and is trading for $4.30, while Astivita remains unchanged, trading for 70 cents apiece

Advance Nanotek (ANO) has teamed up with Astivita (AIR) to create an antimicrobial hand, face and body moisturiser.

In their bid to create the products and get them on the market, the companies have filed a joint patent application.

The moisturiser will include SPF15, which has a percentage of zinc and hinokitiol.

The Advance Nanotek board has stated there are no claims that this product will cure COVID-19 or prevent the virus being contracted. However, the product has been sent to MSL Solutions to test its effectiveness against COVID-19.

How does this test work? Well, the product is tested against the feline coronavirus which is the ‘surrogate’ for COVID-19.

The results won’t be received for some weeks.

For the 2020 financial year, the company said revenue will not be impacted by these products and cannot yet predict what impact there’ll be, if any, for the 2021 financial year.

In March, Advance Nanotek released an announcement regarding a patent application, which saw the company’s shares being suspended for a prolonged period.

“Although the Board doesn’t necessarily agree with the market relevance of the questions or the responses to those questions, the Board is eager to avoid a further unnecessary suspension,” the company said.

Due to this, the company went into detail about the patent in its announcement.

On market close, Advance Nanotek is up 1.18 per cent and is trading for $4.30, while Astivita remains unchanged, trading for 70 cents apiece.

ANO by the numbers
More From The Market Herald

" Mighty Craft (ASX:MCL) signs agreement with DB Breweries and Better Beer in New Zealand

Mighty Craft (ASX:MCL) has signed a binding agreement with DB Breweries and Better Beer Company to…
RooLife Group (ASX:RLG) - Managing Director, Bryan Carr

" RooLife Group (ASX:RLG) and AFT Pharmaceuticals (ASX:AFP) launches OTC medicines online in China

RooLife Group (ASX:RLG) and AFT Pharmaceuticals (ASX:AFP) have launched a range of over-the-counter (OTC) medicines online…

" Burgundy Diamond Mines (ASX:BDM) launches Maison Mazerea in Paris

Burgundy Diamond Mines (ASX:BDM) has officially launched its new ultra-luxury diamond brand Maison Mazerea in Paris.

" Tour de France: BikeExchange (ASX:BEX)-sponsored team wins Stage 3, breaking three-year drought

Dutch sprinter Dylan Groenewegen crashed less than 10 kilometres from the finish line of stage three…